# Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.

> **NCT06638710** · PHASE2 · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 30 (estimated)

## Conditions studied

- Neurocognitive Disorders

## Interventions

- **DRUG:** oral administration of midazolam or placebo

## Key facts

- **NCT ID:** NCT06638710
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638710, "Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06638710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*